Comparison Chart Synlogic, Inc.

Stocks

SYBX

US87166L2097

Biotechnology & Medical Research

Market Closed - OTC Markets 21:23:43 08/09/2026 +04			5-day change	1st Jan Change
1.175 ^USD	+0.43%		-3.69%	+4.91%

08-12	Synlogic, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-29	Caldera Therapeutics, Inc. entered into an agreement and plan of merger to acquire Synlogic, Inc. for an enterprise value of approximately $500 million in a reverse merger transaction.	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	SYNLOGIC, INC.	Other Biotechnology & Medical Research	+0.43%	-3.69%	+4.91%	-20.07%	-97.57%	13.69M	-	-	-